Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine

British Journal of Pharmacology

Volumn 121, Issue 6, 1997, Pages 1136-1140

  Furukawa, Taiji ^a   Nukada, Toshihide ^b   Suzuki, Kazuyuki ^a   Fujita, Yoshihiko ^c   Mori, Yasuo ^d   Nishimura, Masao ^a   Yamanaka, Masami ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Amlodipine; Dihydropyridine; N type Ca2+ channel

Indexed keywords

AMLODIPINE; BARIUM ION; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DRUG POTENCY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; FEMALE; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; TIME; XENOPUS;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CLONING, MOLECULAR; HYDROGEN-ION CONCENTRATION; RECOMBINANT PROTEINS; XENOPUS;

EID: 0030841682     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701226     Document Type: Article

References (21)

1. ABERNETHY, D.R., GUTKOWSKA, J. & LAMBERT, M.D. (1988). Amlodipine in elderly hypertensive patients: Pharmacokinetics and pharmacodynamics. J. Cardiovasc. Pharmacol., 12 (Suppl 7), S67-71.
2. 2+ channel. FEBS Letts, 377, 159-162.
3. BURGES, R.A., DODD, M.G. & GARDINER, D.G. (1989). Pharmacologic profile of amlodipine. Am. J. Cardiol., 64, 10i-18i.
4. DONATI, L., BUHLER, F.R., BERETTA PICCOLI, C., KUSCH, F. & HEINEN, G. (1992). Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. Clin. Pharmacol. Ther., 52, 50-59.
5. ELLINOR, P.T., ZHANG, J,-F., HORNE, W.A. & TSIEN, R.W. (1995). Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature, 372, 272-275.
6. ELLIOTT, H.L. & MEREDITH, P.A. (1991). The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine. Postgrad. Med. J., 67 Suppl 3, S20-S23.
7. FUJITA, Y., MYNLIEFF, M., DIRKSEN, R.T., KIM, M.-S., NIIDOME, T., NAKAI, J., FRIEDRICH, T., IWABE, N., MIYATA, T., FURUICHI, T., FURUTAMA, D., MIKOSHIBA, K., MORI, Y. & BEAM, K.G. (1993). Primary structure and functional expression of the ω-conotoxin-sensitive N-type calcium channel from rabbit brain. Neuron., 10, 585-598.
8. GRABNER, M., WANG, Z., HERING, S., STIESSNIG, J. & GLOSSMANN, H. (1996). Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron, 16, 207-218.
9. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science, 239, 57-61.
10. KAPLAN, N.M. (1991). Amlodipine in the treatment of hypertension. Postgrad. Med. J., 67 (Suppl 5), S15-S19.
11. KASS, R.S. & ARENA, J.P. (1989). Influence of pHo on calcium channel block by amlodipine, a charged dihyfropyridine compound. Implications for location of the dihydropyridine receptor. J. Gen. Physiol., 93, 1109-1127.
12. LEENEN, F.H.H. & FOURNEY, A. (1996). Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am. J. Cardiol., 78, 203-207.
13. LOPEZ, L.M., THORMAN, A.D. & MEHTA, J.L. (1990). Effects of amlodipine on blood pressure, heart rate, cartecholamines, lipids and responses to adrenergic stimulus. Am. J. Cardiol., 66, 1269-1271.
14. MASON, R.P., CAMPBELL, S.F., WANG, S.-D. & HERBETTE, L.G. (1989). Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Mol. Pharmacol., 36, 634-640.
15. MIKAMI, A., IMOTO, K., TANABE, T., NIIDOME, T., MORI, Y., TAKESHIMA, H., NARUMIYA, S. & NUMA, S. (1989). Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature, 340, 230-233.
16. MORI, Y., FRIEDRICH, T., KIM, M.-S., MIKAMI, A., NAKAI, J., RUTH, P., BOSSE, E., HOFMANN, F., FLOCKERZI, V., FURUICHI, T., MIKOSHIBA, K., IMOTO, K., TANABE, T. & NUMA, S. (1991). Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature, 350, 398-402.
17. NAKAMURA, F., OGATA, K., SHIOZAKI, K., KAMEYAMA, K., OHARA, K., HAGA, T. & NUKADA, T. (1991). Identification of two novel GTP-binding protein α-subunits that lack apparent ADP-ribosylation sites for pertussis toxin. J. Biol. Chem., 266, 12676-12681.
18. NAYLER, W.G. & GU, X.H. (1991). (-)[3H]amlodipine binding to rat cardiac membranes. J. Cardiovasc. Pharmacol., 17, 587-592.
19. PETERSON, B.Z., TANADA, T.N. & CATTERALL, W.A. (1996). Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels. J. Biol. Chem., 271, 5293-5296.
20. TAKAO, K., YOSHII, M., KANDA, A., KOKUBUN, S. & NUKADA, T. (1994). A region of the muscarinic-gated atrial potassium channel critical for activation by G-protein βγ-subunits. Neuron, 13, 747-755.
21. 2+ channels. Trends Pharmacol. Sci., 12, 349-354.